# Principal Scientist – Biotransformation, PKDM-BA — Amgen

- Location: California
- Posted: Nov 19, 2026
- Status: open (checked Nov 21, 2026)
- Apply (employer's site): https://amgen.wd1.myworkdayjobs.com/Careers/job/US---California---South-San-Francisco/Principal-Scientist---Biotransformation--PKDM-BA_R-261325
- Employer record: https://visajobs.io/company/amgen.md

## Sponsorship history
- Tier: Strong history
- Occupation (SOC): Medical Scientists, Except Epidemiologists (19-1042)
- Employer's certified LCAs for this occupation in CA, FY2024–FY2026: 31
- …in the whole US: 53
- With this exact title: 0
- Median DOL prevailing wage, level I / II: $78k / $108k

## Description
Career Category
Scientific
Job Description
Join Amgen’s Mission of Serving Patients
At Amgen, if you feel like you’re part of something bigger, it’s because you are. Our shared mission—to serve patients living with serious illnesses—drives all that we do.
Since 1980, we’ve helped pioneer the world of biotech in our fight against the world’s toughest diseases. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat heart disease, obesity and obesity-related conditions, rare diseases, inflammatory conditions and cancer. As a member of the Amgen team, you’ll help make a lasting impact on the lives of patients as we research, manufacture, and deliver innovative medicines to help people live longer, fuller happier lives.
Our award-winning culture is collaborative, innovative, and science based. If you have a passion for challenges and the opportunities that lay within them, you’ll thrive as part of the Amgen team. Join us and transform the lives of patients while transforming your career.
Principal Scientist – Biotransformation
What you will do
Let’s do this. Let’s change the world. In this vital role you will provide hands-on scientific leadership supporting small-molecule therapeutics, including heterobifunctional targeted protein degraders and other related modalities, across discovery and development.
In this laboratory-based role, you will design and execute studies to identify and characterize metabolites, define metabolic pathways, investigate mechanisms contributing to clearance, and understand how molecular structure influences biotransformation. You will translate these findings into recommendations that guide medicinal chemistry, drug-candidate selection, and development planning.
The role combines direct experimental contribution with scientific leadership and collaboration across disciplines. You will work with medicinal chemistry, pharmacology, ADME, pharmacokinetics, bioanalysis, toxicology, clinical pharmacology, and regulatory colleagues to address program-specific questions and communicate the implications of your findings.
Key Responsibilities:
· Lead the design, execution, and interpretation of biotransformation studies supporting small-molecule programs from discovery optimization through development.
· Develop, optimize, and apply LC–high-resolution tandem mass spectrometry methods for metabolite profiling, identification, and structural characterization in in vitro systems and biological samples.
· Define metabolic pathways and transformation sites, establish confidence in proposed metabolite structures, and pursue additional analytical or experimental confirmation when appropriate.
· Characterize human-relevant and cross-species metabolic pathways, including contributions from CYP and non-CYP enzymes, in collaboration with appropriate ADME experts. Integrate these findings with pharmacokinetic observations to investigate potential contributions to clearance and exposure.
· Distinguish enzyme-mediated metabolism from chemical instability, sample-handling degradation, nonspecific binding, and incomplete analytical recovery. Establish controls that support reliable interpretation of parent disappearance and metabolite formation.
· Partner with medicinal chemistry to identify metabolic liabilities and evaluate structural modifications. Interpret biotransformation findings alongside other ADME, pharmacokinetic, and pharmacological properties to support compound optimization.
· Support development-stage metabolite characterization, cross-species comparisons, and assessments of metabolite exposure and coverage. Collaborate with toxicology, clinical pharmacology, and regulatory partners to address the significance of relevant metabolites.
· Explore and benchmark emerging AI/ML approaches to streamline MetID data analysis, interpretation, visualization, and scientific communication, including report and presentation preparation. Pilot promising workflows and advance those that deliver measurable improvements in efficiency, consistency, and scientific quality.
· Represent biotransformation in multidisciplinary project discussions, communicate recommendations and uncertainties, and help define studies needed to resolve important program questions.
· Strengthen experimental and analytical capabilities through troubleshooting methods, evaluation of new technologies, automation, and effective data-processing approaches.
· Maintain clear experimental records, prepare scientific reports and presentations, and contribute to publications and external scientific discussions. Share technical knowledge and mentor colleagues through experimental planning, troubleshooting, and data interpretation.
What we expect of you
We are all different, yet we all use our unique contributions to serve patients. The Principal Scientist we seek is a researcher with these qualifications.
Basic Qualifications:
PhD, PharmD, or MD, with relevant postdoctoral training where applicable, and 2 years of experience in the scientific discipline or subdiscipline applicable to the role;
OR
Master’s degree and 5 years of experience in the scientific discipline or subdiscipline applicable to the role;
OR
Bachelor’s degree and 7 years of experience in the scientific discipline or subdiscipline applicable to the role.
Preferred Qualifications:
· Hands-on experience investigating the biotransformation of small-molecule drug candidates, including metabolite profiling, identification, and characterization in biological matrices.
· Expertise in LC–HRMS/MS method development, chromatographic separation, sample preparation, interpretation of fragmentation data, and analytical troubleshooting.
· Strong understanding of organic chemistry, drug-metabolism pathways, enzyme kinetics, and experimental approaches used to investigate metabolic mechanisms.
· Experience selecting and applying in vitro metabolism systems, including hepatocytes, relevant enzyme systems, and hepatic and extrahepatic microsomal and c

> History, not a promise: past H-1B filings do not mean an employer will sponsor you or a given role. Data: U.S. DOL OFLC LCA disclosure (FY2024–FY2026 for role counts, certified LCAs) and the USCIS H-1B Employer Data Hub. Not legal advice. Methodology: https://visajobs.io/methodology
